Relcovaptan - CISMeF

Preferred Label : Relcovaptan;

NCIt synonyms : 1-(5-Chloro-3-(2-chlorophenyl)-1-(3,4-dimethoxybenzenesulfonyl)-3-hydroxy-2,3-dihydro-1H-indole-2-carbonyl)pyrrolidine-2-carboxamide; SR 49059;

NCIt related terms : SR49059;

Alternative definition : NCI-GLOSS: A substance being studied in the treatment of cancer. It inhibits a hormone growth factor that causes some cancer cells to divide. It is a type of vasopressin receptor antagonist.;

UNII : C1GL8G6G0O;

InChIKey : CEBYCSRFKCEUSW-NAYZPBBASA-N;

CAS number : 150375-75-0;

Molecule name : SR-49059;

Codes from synonyms : CDR0000046690;

Details

Origin ID

C1497;

UMLS CUI

C0218068;

Automatic exact mappings (from CISMeF team)
- SR 49059 [MeSH concept]
Currated CISMeF NLP mapping
- relcovaptan [MeSH concept]
- relcovaptan [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- relcovaptan [MeSH concept]
- relcovaptan [MeSH Supplementary Concept]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]
- NCI Drug Dictionary Terminology [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients